UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information

Not Applicable

Completed

Conditions: Alcohol Consumption

Interventions: Behavioral: Lab-based Cue Reactivity Personalized Feedback Intervention (PFI)

First Posted Date: 2023-05-24

Last Posted Date: 2024-05-02

Lead Sponsor: University of Washington

Target Recruit Count: 117

Registration Number: NCT05873556

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program

Not Applicable

Recruiting

Conditions: STI
HIV Prevention
Pre-exposure Prophylaxis

Interventions: Other: Health service - home-based PrEP monitoring

First Posted Date: 2023-05-12

Last Posted Date: 2024-05-10

Lead Sponsor: University of Washington

Target Recruit Count: 458

Registration Number: NCT05856942

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

First in Human Study of TLC-ART 101 (ACTU 2001)

Phase 1

Completed

Conditions: Treatment
Human Immunodeficiency Virus
Antiretroviral Therapy

Interventions: Drug: TLC-ART

First Posted Date: 2023-05-09

Last Posted Date: 2024-12-11

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT05850728

Locations: 🇺🇸
UW Positve Research, Harborview Medical Center, Seattle, Washington, United States

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

Phase 1

Completed

Conditions: Metastatic Malignant Solid Neoplasm
Hematopoietic and Lymphatic System Neoplasm

Interventions: Other: Counseling
Drug: Psilocybin
Other: Questionnaire Administration

First Posted Date: 2023-05-08

Last Posted Date: 2024-11-12

Lead Sponsor: University of Washington

Target Recruit Count: 55

Registration Number: NCT05847686

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

Not Applicable

Completed

Conditions: Fatigue
Multiple Sclerosis

Interventions: Behavioral: 4-week Behavioral Activation
Behavioral: 4-week Relaxation Training
Behavioral: 4-week Cognitive Therapy

First Posted Date: 2023-05-08

Last Posted Date: 2024-12-12

Lead Sponsor: University of Washington

Target Recruit Count: 21

Registration Number: NCT05848323

Locations: 🇺🇸
Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle, Washington, United States

Early Feasibility Study of a Novel Negative Pressure Wound Therapy Glove for Hand Injuries

Not Applicable

Recruiting

Conditions: Hand Injuries

Interventions: Device: ReHeal glove with Negative Pressure Wound Therapy (NPWT)

First Posted Date: 2023-05-06

Last Posted Date: 2024-10-26

Lead Sponsor: University of Washington

Target Recruit Count: 10

Registration Number: NCT05844943

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Cubii for Exercise in People With MS

Not Applicable

Completed

Conditions: Multiple Sclerosis
Activity, Motor
Fatigue
Quality of Life

Interventions: Device: Cubii elliptical

First Posted Date: 2023-04-24

Last Posted Date: 2024-12-03

Lead Sponsor: University of Washington

Target Recruit Count: 21

Registration Number: NCT05826431

Locations: 🇺🇸
UW Medicine, Seattle, Washington, United States

Pilot Mobile for Dementia and Frailty

Phase 1

Completed

Conditions: Dementia
Frailty

Interventions: Other: Usual Care
Other: Mobile app

First Posted Date: 2023-04-24

Last Posted Date: 2024-07-03

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT05827094

Locations: 🇺🇸
Univeristy of Washington, Seattle, Washington, United States

CASI-Plus mHealth for Ukraine's APS Program

Not Applicable

Recruiting

Conditions: HIV Infections

Interventions: Behavioral: CASI-Plus

First Posted Date: 2023-04-24

Last Posted Date: 2024-06-27

Lead Sponsor: University of Washington

Target Recruit Count: 1124

Registration Number: NCT05826977

Locations: 🇺🇦
• Municipal Enterprise "Chernihiv Regional Hospital" of the Chernihiv Regional Council "Center for HIV/AIDS and Hepatitis Prevention", Chernihiv, Ukraine
🇺🇦
• Municipal Enterprise "Dnipropetrovsk Regional Medical Center for Socially Significant Diseases" of the Dnipropetrovsk Regional Council, Dnipro, Ukraine

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Phase 2

Recruiting

Conditions: Diabetic Kidney Disease
Type 1 Diabetes

Interventions: Other: Placebo
Drug: Semaglutide

First Posted Date: 2023-04-21

Last Posted Date: 2024-06-06

Lead Sponsor: University of Washington

Target Recruit Count: 60

Registration Number: NCT05822609

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
University of Washington, Seattle, Washington, United States
🇨🇦
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy